Best Oncology Doctors Abroad

OÄ Dr. med. Tamara Arnoldner is a specialist in dermatology and venereology at JUVENIS Medical Center. She worked there as a locum in May 2024 and has been a cooperating physician since March 2025. She is also a senior physician at the Department of Dermatology, Medical University of Vienna, since November 2024.

Training: M.D., Medical University of Vienna (2015). Basic clinical training at Rudolfstiftung (2015–2016). Rotation at University Hospital St. Pölten (2016). Specialist training in dermatology and venereology (2017–2022). Specialization in allergology since 2022. Certified atopic dermatitis trainer (2017).

Focus: atopic dermatitis; allergy diagnosis and treatment (allergy chip, prick and patch tests, specific immunotherapy); hair loss; inflammatory skin diseases; skin cancer screening and dermatologic surgery; acne, rosacea, hidradenitis; psoriasis; aesthetic dermatology (botulinum toxin, hyaluronic acid, mesotherapy, microneedling, plasma therapy). She provides integrated medical and aesthetic care.

Professor Kim Hyun-hoe is a urologic cancer surgeon. He specializes in prostate and kidney cancer and robotic surgery. He directs Myongji Hospital’s Robotic Surgery Center and the Prostate & Kidney Cancer Center. He performed Korea’s first single-incision laparoscopy. At SNUH, he led more than 2,300 da Vinci cases over five years. He now uses the da Vinci Xi system.

He holds an MD, MS, and PhD from Seoul National University. He is a former director of SNUH Robotic Surgery and the Urology/Prostate Cancer Center. He is a past president of the Korean Society of Endourology and Robotics. He is a council member of the Korean Urological Association. His awards include the WCE Best Laparoscopy/Robotic Paper and the KUA Best Paper. He has also received several national academic honors. He contributes to next‑generation da Vinci research with Seoul National University and Intuitive Surgical. This was the first such collaboration in Asia.

Dr. Shute Ailia DAE is a medical oncologist at Optimed International Çorlu Hospital. Dr. Ailia graduated from Dokuz Eylül University Faculty of Medicine in 2013 and completed an internal medicine residency at Bezmialem Vakıf University Hospital in 2018. A hematology–oncology fellowship at Başkent University Hospital followed in 2023.

From 2018 to 2020, Dr. Ailia served as an internal medicine specialist at Bezmialem Vakıf University Hospital. From 2023 to 2024, Dr. Ailia was an instructor in medical oncology at Başkent University Adana Dr. Turgut Noyan Practice and Research Center.

Clinical focus includes breast, lung, and prostate cancers. It also covers gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, and gynecologic and genitourinary cancers. Languages: English, Turkish, Swahili.

Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.

He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.

Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.

Specialist in endoprosthetics – Dr. Dekel focuses on artificial joint replacements often needed after complex bone tumor surgery at Assuta Medical Center.

• Expert in limb reconstruction and tumor removal surgery
• Focuses on joint replacement for musculoskeletal cancers
• Based at the Assuta Medical Center

Professor Bosch is a globally recognized leader in Chronic Lymphocytic Leukemia (CLL), pioneering new treatments and diagnostic technologies.

• Leads 80+ clinical trials from phase 1 to phase 3
• Head of Hematology at Vall d'Hebron University Hospital
• Published 100+ articles in top medical journals
• Specializes in molecular pathogenesis of CLL
• President of Spanish CLL study group (GELLC)

Principal Investigator in multiple clinical trials for ovarian, cervical, and endometrial cancer – Dr. Oaknin brings advanced research directly to patient care.

• Leading expert in angiogenesis and DNA repair for gynecological cancers
• Author of 100+ publications and presentations in oncology
• Co-Chair of GEICO, Spain's ovarian cancer research group
• Faculty member for Gyn-Track in ESMO and ASCO member